Skip to main content

Table 1 General characteristic of study participants

From: Effect of synbiotic bread containing lactic acid on glycemic indicators, biomarkers of antioxidant status and inflammation in patients with type 2 diabetes: a randomized controlled trial

VariableStudy groupsP-value a
I: Control bread ( n = 25)II: Lactic acid bread (n = 25)III: Synbiotic bread (n = 25)IV: Synbioti  + lactic acid bread (n = 25)
Age (years)54.60 ± 0.8355.00 ± 0.9754.92 ± 1.0253.88 ± 1.090.84
Height (cm)168.48 ± 1.57169.60 ± 1.59170.96 ± 1.47167.72 ± 1.530.47
Weight at study baseline (kg)75.80 ± 0.9375.48 ± 1.6776.28 ± 0.7974.64 ± 1.260.80
Weight at end-of-trial (kg)75.72 ± 0.9075.48 ± 1.5975.76 ± 0.7974.72 ± 1.230.91
Weight change (kg)− 0.08 ± 0.320.00 ± 0.29− 0.52 ± 0.210.08 ± 0.340.67
BMI at study baseline (kg/m2)27.04 ± 0.5026.33 ± 0.4626.39 ± 0.5126.83 ± 0.420.67
BMI at end-of-trial (kg/m2)26.61 ± 0.4126.28 ± 0.4425.70 ± 0.5026.30 ± 0.410.54
BMI change (kg/m2)− 0.44 ± 0.19− 0.05 ± 0.14− 0.68 ± 0.24− 0.52 ± 0.180.14
Metformin use (n/day)2.00 ± 0.122.00 ± 0.281.70 ± 0.262.00 ± 0.220.98
Glibenclamide use (n/day)1.2 ± 0.161.00 ± 0.222.00 ± 0.181.80 ± 0.220.88
  1. All values are mean ± SEM
  2. BMI body mass index
  3. aObtained from One-way ANOVA